Open AccessModification of the existing maximum residue levels for emamectin in various crops
Author(s) -
Bellisai Giulia,
Bernasconi Giovanni,
Brancato Alba,
Carrasco Cabrera Luis,
Ferreira Lucien,
Giner German,
Greco Luna,
Jarrah Samira,
Kazocina Aija,
Leuschner Renata,
Magrans Jose Oriol,
Miron Ileana,
Nave Stefanie,
Pedersen Ragnor,
Reich Hermine,
Ruocco Silvia,
Santos Miguel,
Scarlato Alessia Pia,
Theobald Anne,
Vagenende Benedicte,
Verani Alessia
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6824
Subject(s) - emamectin benzoate , risk assessment , emamectin , residue (chemistry) , enforcement , toxicology , agriculture , food safety , business , agricultural science , environmental science , pesticide , biology , food science , agronomy , computer science , ecology , biochemistry , computer security
In accordance with Article 6 of Regulation ( EC ) No 396/2005, the applicant Syngenta France S.A.S. submitted a request to the competent national authority in France to modify the existing maximum residue levels ( MRL s) for emamectin. The data submitted in support of the request were found to be sufficient to derive MRL proposals for apricots, cherries, spinaches and similar leaves and herbal infusions from leaves and herbs, whereas a change of the existing MRL is not necessary for pome fruits. Adequate analytical methods for enforcement are available to control the residues of emamectin B1a on the commodities under consideration. Based on the risk assessment results, EFSA concluded that the short‐term and long‐term intake of residues resulting from the uses of emamectin benzoate according to the intended agricultural practices are unlikely to present a risk to consumer health. The consumer risk assessment shall be regarded as indicative since affected by uncertainty related to the data gaps identified in the MRL review.